血友病的基因疗法 - - 从基础科学到首次批准"一刀切"疗法
Roland W Herzog1, Radoslaw Kaczmarek1, Katherine A High2
1Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
概括
使用腺相关病毒载体的基因疗法在血友病治疗方面表现有前途,只需一次剂量就能提供长期纠正. 虽然免疫反应等挑战仍然存在,但正在进行的研究和新方法正在推动这一领域的发展.
科学领域:
- *基因治疗和分子医学
- * 血液学和凝血障碍 血液学和凝血障碍
背景情况:
- *血友病是一种X系相关的出血障碍,需要终身使用因子替代疗法进行治疗.
- *基因疗法为A型和B型血友病提供了潜在的一次性治愈治疗.
- * 腺相关病毒 (AAV) 基因转移到肝细胞已成为主要策略.
研究的目的:
- * 审查血友病基因治疗的进展和挑战.
- *为了突出体内AV基因转移在临床试验和批准产品中的成功.
- *讨论新兴的替代基因治疗方法.
主要方法:
- *对临床前研究和临床试验的审查,涉及对血友病的AAV基因转移.
- *对经批准的基因疗法产品对血友病B和A的结果进行分析.
- *对基因编辑和ex vivo基因疗法的正在进行的研究进行审查.
主要成果:
- *在一些患者中,持续部分到完全的凝血纠正持续了长达十年.
- * 对治疗血友病B和A的基因疗法产品的监管批准.
- *识别挑战,包括AAV免疫力,毒性和变量表达.
结论:
- *活体AAV基因疗法在血友病治疗中取得了重要的里程碑.
- *工程因素变体和基因编辑等替代方法正在开发中.
- * 持续的研究对于解决剩余的挑战和优化持久表达至关重要.
相关概念视频
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


